Choosing the appropriate pharmacotherapy for Morgellons disease: an expert perspective

Esther A Balogh; Katherine G Beuerlein; Steven R Feldman

doi:10.1080/14656566.2022.2029407

Choosing the appropriate pharmacotherapy for Morgellons disease: an expert perspective

Expert Opin Pharmacother. 2022 Apr;23(5):527-530. doi: 10.1080/14656566.2022.2029407. Epub 2022 Jan 25.

Authors

Esther A Balogh¹, Katherine G Beuerlein¹, Steven R Feldman^{1

2

3

4}

Affiliations

¹ Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
² Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
³ Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
⁴ Department of Dermatology, University of Southern Denmark, Odense, Denmark.

PMID: 35076344
DOI: 10.1080/14656566.2022.2029407

No abstract available

Keywords: Aripiprazole; delusional infestation; delusional parasitosis; first-generation antipsychotic; morgellons disease; olanzapine; pimozide; risperidone; second generation antipsychotic; somatic symptom disorder.

Publication types

Editorial

MeSH terms

Antipsychotic Agents* / therapeutic use
Aripiprazole
Humans
Morgellons Disease* / drug therapy

Substances

Antipsychotic Agents
Aripiprazole